Oral Contraceptive and Cardiovascular Risk in PCOS
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Oral contraceptive therapy is routinely used for the treatment of menstrual disturbances of
patients with polycystic ovary syndrome (PCOS).
To date, the cardiovascular risk (CVR) of the oral contraceptives (OC) are known but no data
are available on the CVR in PCOS patients treated with OC or physical exercise.
The purpose of this study is to compare the effects of OC to physical exercise on the CVR of
PCOS women and show the hormonal and metabolic effects of these two different treatment.
We hypothesize that physical exercise has the same beneficial effects of OC therapy on
hormonal and metabolic features of PCOS women with less cardiovascular consequences.